Literature DB >> 16986032

Interstitial cystitis-epidemiology, diagnostic criteria, clinical markers.

Philip M Hanno.   

Abstract

Knowledge of the epidemiology of interstitial cystitis (IC), the burden of the disease in the population, and the identification of possible risk factors remains largely fragmentary. The most reliable information comes from the few population-based studies that have appeared in the literature over the past 25 years, but two major issues urgently need to be addressed by appropriate epidemiologic studies: although studies find that only 10% of IC occurs in men, the hallmark symptoms of chronic prostatitis-pelvic pain, voiding dysfunction, and pain associated with sexual activity-overlap with those in men who carry the IC diagnosis. In addition, it is not known whether children suffer from the condition. The definition of IC is grounded in the symptomatology of pelvic pain and urinary frequency of a chronic nature and unexplained by any known urologic or other system pathology, but undue reliance on cystoscopic criteria has undoubtedly led to significant underdiagnosis. Efforts to identify clinical markers for diagnosis of IC are continuing and may lead the way to ascertaining the etiology and pathophysiology of IC.

Entities:  

Year:  2002        PMID: 16986032      PMCID: PMC1476008     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  17 in total

1.  Interstitial cystitis: unexplained associations with other chronic disease and pain syndromes.

Authors:  M Alagiri; S Chottiner; V Ratner; D Slade; P M Hanno
Journal:  Urology       Date:  1997-05       Impact factor: 2.649

Review 2.  Epidemiology of interstitial cystitis.

Authors:  C A Jones; L Nyberg
Journal:  Urology       Date:  1997-05       Impact factor: 2.649

3.  Epidemiology of interstitial cystitis.

Authors:  J A Koziol
Journal:  Urol Clin North Am       Date:  1994-02       Impact factor: 2.241

Review 4.  The epidemiology of interstitial cystitis: is it time to expand our definition?

Authors:  J W Kusek; L M Nyberg
Journal:  Urology       Date:  2001-06       Impact factor: 2.649

5.  Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor as urine markers for interstitial cystitis.

Authors:  S K Keay; C O Zhang; J Shoenfelt; D R Erickson; K Whitmore; J W Warren; R Marvel; T Chai
Journal:  Urology       Date:  2001-06       Impact factor: 2.649

6.  Interstitial cystitis: current issues and controversies in diagnosis.

Authors:  G R Sant; P M Hanno
Journal:  Urology       Date:  2001-06       Impact factor: 2.649

7.  The urinary glycoprotein GP51 as a clinical marker for interstitial cystitis.

Authors:  D S Byrne; J F Sedor; J Estojak; K J Fitzpatrick; A N Chiura; S G Mulholland
Journal:  J Urol       Date:  1999-06       Impact factor: 7.450

8.  Quality of life among women with interstitial cystitis.

Authors:  Y L Michael; I Kawachi; M J Stampfer; G A Colditz; G C Curhan
Journal:  J Urol       Date:  2000-08       Impact factor: 7.450

9.  Idiopathic reduced bladder storage versus interstitial cystitis.

Authors:  S A Awad; S MacDiarmid; J B Gajewski; R Gupta
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

10.  Epidemiology of interstitial cystitis: a population based study.

Authors:  G C Curhan; F E Speizer; D J Hunter; S G Curhan; M J Stampfer
Journal:  J Urol       Date:  1999-02       Impact factor: 7.450

View more
  13 in total

1.  Artemin Immunotherapy Is Effective in Preventing and Reversing Cystitis-Induced Bladder Hyperalgesia via TRPA1 Regulation.

Authors:  Jennifer J DeBerry; Jami L Saloman; Brian K Dragoo; Kathryn M Albers; Brian M Davis
Journal:  J Pain       Date:  2015-04-17       Impact factor: 5.820

Review 2.  Interventional therapies for controlling pelvic pain: what is the evidence?

Authors:  Isabel C Green; Sarah L Cohen; Dayna Finkenzeller; Paul J Christo
Journal:  Curr Pain Headache Rep       Date:  2010-02

3.  Dissimilar effects of tolterodine on detrusor overactivity in awake rats with chemical cystitis and partial bladder outlet obstruction.

Authors:  Long-Hu Jin; Chang-Shin Park; Hwa-Yeon Shin; Sang-Min Yoon; Tack Lee
Journal:  Int Neurourol J       Date:  2011-09-30       Impact factor: 2.835

4.  Role of inflammation in bladder function and interstitial cystitis.

Authors:  Sonal Grover; Abhishek Srivastava; Richard Lee; Ashutosh K Tewari; Alexis E Te
Journal:  Ther Adv Urol       Date:  2011-02

5.  Sleep disturbances and nocturnal symptoms: relationships with quality of life in a population-based sample of women with interstitial cystitis/bladder pain syndrome.

Authors:  Wendy M Troxel; Marika Booth; Daniel J Buysse; Marc N Elliott; Anne M Suskind; J Quentin Clemens; Sandra H Berry
Journal:  J Clin Sleep Med       Date:  2014-12-15       Impact factor: 4.062

6.  TGR5 agonists induce peripheral and central hypersensitivity to bladder distension.

Authors:  Ashlee Caldwell; Luke Grundy; Andrea M Harrington; Sonia Garcia-Caraballo; Joel Castro; Nigel W Bunnett; Stuart M Brierley
Journal:  Sci Rep       Date:  2022-06-15       Impact factor: 4.996

Review 7.  Glycosylation of uroplakins. Implications for bladder physiopathology.

Authors:  Iwona Kątnik-Prastowska; Jolanta Lis; Agata Matejuk
Journal:  Glycoconj J       Date:  2014-11-15       Impact factor: 2.916

8.  Development of an interstitial cystitis risk score for bladder permeability.

Authors:  Laura E Lamb; Joseph J Janicki; Sarah N Bartolone; Kenneth M Peters; Michael B Chancellor
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

9.  Interstitial Cystitis or Painful Bladder Syndrome in a Premenopausal Female Precipitated by Oral Combined Contraceptives.

Authors:  Anna Thompson; Ashley E Siegel; Zachery Thompson; John M Tramont
Journal:  Cureus       Date:  2020-05-29

Review 10.  The enigma of men with interstitial cystitis/bladder pain syndrome.

Authors:  Hans C Arora; Daniel A Shoskes
Journal:  Transl Androl Urol       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.